Effect of dexamethasone as an additive to bupivacaine for pain relief in children

Effect of dexamethasone as an adjuvant on analgesic efficacy of bupivacaine in caudal block in pediatric infraumbilical surgeries - Not applicable

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061537

Enrollment

Registered

2024-01-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine + Dexamethasone: . Intervention2: Bupivacaine with Dexamethasone: Using dexamethasone as an adjuvant Intervention3: Single shot caudal anaesthesia Bupivacaine(0.25%) 2mg/kg

Eligibility

Inclusion criteria

Inclusion criteria: ASA I II III Consent from legally authorized representative Infraumbilical surgeries

Exclusion criteria

Exclusion criteria: ASA IV V Refusing to give consent Patient with pre existing cardiac, neurological and respiratory diseases Patients having coagulopathy Patient with congenital spine anomaly local infection

Design outcomes

Primary

Measure	Time frame
To study postoperative pain relief in both groups Timepoint: Pain profile is measured in terms of FLACC scale 24 hours post operatively every 15 minutes for 1 hr and every half hour for next 4 hours and hourly till 24 hrs	—

Secondary

Measure	Time frame
To compare postoperative complication in both groups. Intraoperative hemodynamic parameters in both groupsTimepoint: 24 hours post operativve	—

Countries

India

Contacts

Public ContactDr Shakuntala J Goswami

B.J. Medical College and Civil Hospital , Ahmedabad

dhrumit09@yahoo.com9327021192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026